SCHEMBL2961222

SCHEMBL2961222

c1cc2ccc3ccc(-c4ccc5cc(-c6ccc7ccc8cccc9ccc6c7c89)ccc5c4)c4ccc(c1)c2c34

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.48
ERBB2 P04626 1/20 0.48
FYN P06241 1/20 0.48
MAOA P21397 1/20 0.48
ACHE P22303 1/20 0.48
AHR P35869 1/20 0.48
ALDH1A1 P00352 5/20 0.47
HPGD P15428 5/20 0.47
HSD17B10 Q99714 4/20 0.47
TSHR P16473 3/20 0.47
CYP3A4 P08684 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP1A1 P04798 2/20 0.46
CYP1B1 Q16678 2/20 0.46
GSTP1 P09211 1/20 0.45
THRB P10828 1/20 0.43
HSD17B1 P14061 4/20 0.40
HSD17B2 P37059 4/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2789566 0.96 GSTP1 (0.52) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL3792915 0.92 GSTP1 (0.55) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL3687907 0.92 GSTP1 (0.55) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL30496688 0.89 CYP2A6 (0.47) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL12826353 0.89 ESR2 (0.53) CYP1A2CYP3A4HSD17B1HSD17B2TLR8
SCHEMBL12107244 0.89 CYP2A6 (0.47) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL28211576 0.89 CYP1A2 (0.55) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL29756488 0.89 CYP1A2 (0.50) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL16177320 0.89 CYP1A2 (0.50) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL2122937 0.89 ALDH1A1 (0.52) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100025661-A1 Luminescent material and organic electroluminescent device using the same JNC CORPORATION (JP) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100025661-A1 Luminescent material and organic electroluminescent device using the same TRPV3, TRPC3, HVCN1 CYP1A2 1391/4885ERBB2 3856/4885FYN 3452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.